CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events

Sponsor
Pfizer (Industry)
Overall Status
Completed
CT.gov ID
NCT00327418
Collaborator
Diabetes UK (Other), Department of Health, United Kingdom (Other)
2,800
135
85
20.7
0.2

Study Details

Study Description

Brief Summary

A study to assess the efficacy of once daily atorvastatin 10 mg versus placebo on cardiovascular endpoints in patients with non-insulin-dependent diabetes mellitus (NIDDM) who have a history of either hypertension, retinopathy, microalbuminuria, macroalbuminuria, or who currently smoke, but who do not have established corornary heart disease or other macrovascular disease.

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Prevention
Official Title:
A Double Blind Placebo Controlled Study of Atorvastatin as Prevention of CHD in High Risk Patients With Non-Insulin Dependent Diabetes Mellitus (Collaborative Atorvastatin Study - CARDS)
Study Start Date :
Jan 1, 1997
Study Completion Date :
Feb 1, 2004

Outcome Measures

Primary Outcome Measures

  1. Time from randomization to the occurrence of a primary clinical endpoint []

  2. i.e. major coronary event or CABG or other coronary revascularization procedure []

  3. or unstable angina or resuscitated cardiac arrest or stroke. []

Secondary Outcome Measures

  1. The incidence rate of a primary clinical and endpoint; the time from randomization []

  2. to the occurrence of and the incidence rate of other parameters e.g. total []

  3. mortality, any cardiovascular event, new PVD etc. and the percent change from []

  4. baseline in various lipid and lipoprotein parameters. []

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
Patients must have a documented history of at least one of the following:
  • Hypertension (defined as systolic blood pressure 140 mmHg or a diastolic blood pressure 90 mmHg (defined as the disapperance of all sound [Korotkoff Phase V] or receiving anti-hypertensive treatment. Blood pressure should be measured after sitting the patient quietly for 3 minutes).

  • Retinopathy (defined as any of the following; non-proliferative retinopathy, pre-pre-proliferative retinopathy, proliferative retinopathy, maculopathy, advanced diabetic eye disease or history of photocoagulation).

  • Microalbuminuria (defined as either, Albumin creatinine ratio > than = to 2.5 mg/mmol, or Albumin excretion rate on a timed collection > than = to 20 mcg/min (> than = to 30 mg/24hrs) on two successive occasions, or a positive micral or other strip test).

  • Macroalbuminuria (defined as either; Albustix or other dipstick evidence of gross proteinuria, Albumin creatinine ratio > than = to 25 mg/mmol; or Albumin excretion rate on a timed collection > than = 200 mcg/min (> than = 300 mg/24hrs) on two sucessive occasions).

  • Current smoker

Exclusion Criteria:
  • Type I Diabetes Mellitus

  • Any major Coronary event prior to entry into the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Pfizer Investigational Site Fosterhill Aberdeen United Kingdom AB25 2XG
2 Pfizer Investigational Site Irvine Ayrshire United Kingdom KA12 0AY
3 Pfizer Investigational Site Midsomer Norton Bath United Kingdom BA3 2UH
4 Pfizer Investigational Site Reading Berkshire United Kingdom RG2 7AG
5 Pfizer Investigational Site Slough Berkshire United Kingdom SL1 2AD
6 Pfizer Investigational Site Maidenhead Berskhire United Kingdom SL6 6EL
7 Pfizer Investigational Site Edgbaston Birmingham United Kingdom B15 2TH
8 Pfizer Investigational Site Frenchay Bristol United Kingdom BS16 1LE
9 Pfizer Investigational Site Llanishen Cardiff United Kingdom CF14 5GJ
10 Pfizer Investigational Site Wrexham Clwydd United Kingdom LL13 7TD
11 Pfizer Investigational Site Bocastle Cornwall United Kingdom PL35 0BG
12 Pfizer Investigational Site Falmouth Cornwall United Kingdom TR11 2LH
13 Pfizer Investigational Site Fowey Cornwall United Kingdom PL23 1DT
14 Pfizer Investigational Site Penzance Cornwall United Kingdom TR18 4JH
15 Pfizer Investigational Site Penzance Cornwall United Kingdom TR19 7HX
16 Pfizer Investigational Site Redruth Cornwall United Kingdom TR15 2LL
17 Pfizer Investigational Site Saltash Cornwall United Kingdom PL12 6DL
18 Pfizer Investigational Site St. Austell Cornwall United Kingdom PL26 7RL
19 Pfizer Investigational Site Truro Cornwall United Kingdom TR1 3LJ
20 Pfizer Investigational Site Chesterfield Derbyshire United Kingdom S40 4TF
21 Pfizer Investigational Site Crownhill, Plymouth Devon United Kingdom PL5 3JB
22 Pfizer Investigational Site Plymouth Devon United Kingdom PL6 7TH
23 Pfizer Investigational Site Plympton Devon United Kingdom PL7 1AD
24 Pfizer Investigational Site Bournemouth Dorset United Kingdom BH7 7DW
25 Pfizer Investigational Site Bournemouth Dorset United Kingdom BH8 9EW
26 Pfizer Investigational Site Epping Essex United Kingdom CM16 6TN
27 Pfizer Investigational Site Southend on Sea Essex United Kingdom SS1 2AB
28 Pfizer Investigational Site Langside Glasgow United Kingdom G42 9TY
29 Pfizer Investigational Site Portsmouth Hampshire United Kingdom PO6 3LY
30 Pfizer Investigational Site Southampton Hampshire United Kingdom SO31 7DQ
31 Pfizer Investigational Site Titchfield Hampshire United Kingdom PO14 4EH
32 Pfizer Investigational Site Hemel Hempstead Hertfordshire United Kingdom HP2 4AD
33 Pfizer Investigational Site Watford Hertfordshire United Kingdom WD18 0HB
34 Pfizer Investigational Site Ryde Isle of Wight United Kingdom PO33 2EH
35 Pfizer Investigational Site Gillingham Kent United Kingdom ME7 5NY
36 Pfizer Investigational Site Hildenborough Kent United Kingdom TN11 9HL
37 Pfizer Investigational Site Tunbridge Wells Kent United Kingdom TN1 2DX
38 Pfizer Investigational Site Bolton Lancashire United Kingdom BL4 0JR
39 Pfizer Investigational Site Ormskirk Lancashire United Kingdom L39 2AZ
40 Pfizer Investigational Site Waterloo Liverpool United Kingdom L22 0LG
41 Pfizer Investigational Site Manchester M15 6sx United Kingdom
42 Pfizer Investigational Site Ashford Middlesex United Kingdom TW15 2TU
43 Pfizer Investigational Site Southall Middlesex United Kingdom UB1 3HW
44 Pfizer Investigational Site Scunthorpe North Lincolnshire United Kingdom DN15 7BH
45 Pfizer Investigational Site Harrogate North Yorkshire United Kingdom HG2 7SX
46 Pfizer Investigational Site Northallerton North Yorkshire United Kingdom DL6 1JG
47 Pfizer Investigational Site Sutton-in-Ashfield Nottinghamshire United Kingdom NG17 4JL
48 Pfizer Investigational Site Worksop Nottinghamshire United Kingdom S80 1HP
49 Pfizer Investigational Site Huthwaite Nottingham United Kingdom NG17 2LR
50 Pfizer Investigational Site Headington Oxford United Kingdom OX3 7LJ
51 Pfizer Investigational Site Haverfordwest Pembrokeshire United Kingdom SA61 1QX
52 Pfizer Investigational Site Haverfordwest Pembrokeshire United Kingdom SA61 2PZ
53 Pfizer Investigational Site Shrewsbury Shropshire United Kingdom SY3 8XG
54 Pfizer Investigational Site Frome Somerset United Kingdom BA11 1EZ
55 Pfizer Investigational Site Weston-Super-Mare Somerset United Kingdom BS23 4TQ
56 Pfizer Investigational Site Sheffield South Yorkshire United Kingdom S5 7HD
57 Pfizer Investigational Site Sheffield South Yorkshire United Kingdom S5 7QB
58 Pfizer Investigational Site Sheffield South Yorkshire United Kingdom S7 2DW
59 Pfizer Investigational Site Stirling Stirlingshire United Kingdom FK8 2AU
60 Pfizer Investigational Site Carshalton Surrey United Kingdom SM5 1AA
61 Pfizer Investigational Site Epsom Surrey United Kingdom KT18 7EG
62 Pfizer Investigational Site Pontarddulais Swansea United Kingdom SA4 1TL
63 Pfizer Investigational Site Dundee Tayside United Kingdom DD1 9SY
64 Pfizer Investigational Site Dundee Tayside United Kingdom DD2 5NH
65 Pfizer Investigational Site Hetton le Hole Tyne & Wear United Kingdom DH5 9EZ
66 Pfizer Investigational Site Gateshead Tyne and Wear United Kingdom NE9 6SX
67 Pfizer Investigational Site Nuneaton Warwickshire United Kingdom CV10 7DJ
68 Pfizer Investigational Site Rugby Warwickshire United Kingdom CV22 5PX
69 Pfizer Investigational Site Lyndon West Bromwich, West Midlands United Kingdom B71 4HJ
70 Pfizer Investigational Site Livingston West Lothian United Kingdom EH54 6PP
71 Pfizer Investigational Site Wolverhampton West Midlands United Kingdom WV10 0QP
72 Pfizer Investigational Site Crawley West Sussex United Kingdom RH10 1LL
73 Pfizer Investigational Site Crawley West Sussex United Kingdom RH10 7DX
74 Pfizer Investigational Site Haywards Heath West Sussex United Kingdom RH16 4EX
75 Pfizer Investigational Site Corsham Wiltshire United Kingdom SN13 9DL
76 Pfizer Investigational Site Trowbridge Wiltshire United Kingdom BA14 7EG
77 Pfizer Investigational Site Trowbridge Wiltshire United Kingdom BA14 9AR
78 Pfizer Investigational Site Warminster Wiltshire United Kingdom BA14 9AA
79 Pfizer Investigational Site Westbury Wiltshire United Kingdom BA13 3JD
80 Pfizer Investigational Site York Yorkshire United Kingdom YO31 8HE
81 Pfizer Investigational Site Ayr United Kingdom KA6 6DX
82 Pfizer Investigational Site Ayr United Kingdom KA7 2AA
83 Pfizer Investigational Site Bath United Kingdom BA1 2SR
84 Pfizer Investigational Site Bath United Kingdom BA1 3NG
85 Pfizer Investigational Site Bath United Kingdom BA2 1NH
86 Pfizer Investigational Site Bath United Kingdom BA2 3HT
87 Pfizer Investigational Site Bath United Kingdom BA2 4BY
88 Pfizer Investigational Site Belfast United Kingdom BT12 6BA
89 Pfizer Investigational Site Belfast United Kingdom BT14 6AB
90 Pfizer Investigational Site Belfast United Kingdom BT9 7AB
91 Pfizer Investigational Site Birmingham United Kingdom B15 2SQ
92 Pfizer Investigational Site Birmingham United Kingdom B37 7TR
93 Pfizer Investigational Site Birmingham United Kingdom B9 5SS
94 Pfizer Investigational Site Cambridge United Kingdom CB2 2QQ
95 Pfizer Investigational Site Chippenham, Wiltshire United Kingdom SN15 2SB
96 Pfizer Investigational Site Co. Dublin United Kingdom
97 Pfizer Investigational Site Coventry United Kingdom CV1 4FH
98 Pfizer Investigational Site Derby United Kingdom DE22 3DT
99 Pfizer Investigational Site Dewsbury United Kingdom WF13 4HS
100 Pfizer Investigational Site Dublin 8 United Kingdom
101 Pfizer Investigational Site Dumfries United Kingdom DG1 4AP
102 Pfizer Investigational Site East Kilbride United Kingdom G75 8RG
103 Pfizer Investigational Site Edinburgh United Kingdom EH16 4SA
104 Pfizer Investigational Site Edinburgh United Kingdom EH4 2XU
105 Pfizer Investigational Site Glasgow United Kingdom G12 0YN
106 Pfizer Investigational Site Glasgow United Kingdom G4 0SF
107 Pfizer Investigational Site Glasgow United Kingdom G51 4TF
108 Pfizer Investigational Site Hartlepool United Kingdom TS24 9AH
109 Pfizer Investigational Site Hertfordshire United Kingdom AL7 4HQ
110 Pfizer Investigational Site Hertfordshire United Kingdom SG1 4AB
111 Pfizer Investigational Site Inverness United Kingdom IV2 3UJ
112 Pfizer Investigational Site Leicester United Kingdom LE5 4PW
113 Pfizer Investigational Site Liverpool United Kingdom L7 8XP
114 Pfizer Investigational Site Llantrisant United Kingdom CF72 8XR
115 Pfizer Investigational Site London United Kingdom N18 1QX
116 Pfizer Investigational Site London United Kingdom NW3 2QG
117 Pfizer Investigational Site London United Kingdom W12 0NN
118 Pfizer Investigational Site London United Kingdom W6 8RF
119 Pfizer Investigational Site Manchester United Kingdom M41 5SL
120 Pfizer Investigational Site Manchester United Kingdom M6 8HD
121 Pfizer Investigational Site Manchester United Kingdom M8 5RB
122 Pfizer Investigational Site Newcastle upon Tyne United Kingdom NE4 6BE
123 Pfizer Investigational Site Nottingham United Kingdom NG7 2UH
124 Pfizer Investigational Site Oldham United Kingdom OL1 2JH
125 Pfizer Investigational Site Paisley United Kingdom PA2 9PN
126 Pfizer Investigational Site Pontefract United Kingdom WF8 1PL
127 Pfizer Investigational Site Southampton United Kingdom SO14 0YG
128 Pfizer Investigational Site Swansea United Kingdom SA1 1HW
129 Pfizer Investigational Site Swansea United Kingdom SA1 4DF
130 Pfizer Investigational Site Wakefield United Kingdom WF1 4DG
131 Pfizer Investigational Site Wigan United Kingdom WN1 1XX
132 Pfizer Investigational Site Wiltshire United Kingdom BA15 1DQ
133 Pfizer Investigational Site Wiltshire United Kingdom SN12 7EA
134 Pfizer Investigational Site Wiltshire United Kingdom SP2 8BJ
135 Pfizer Investigational Site Wishaw United Kingdom ML2 0DP

Sponsors and Collaborators

  • Pfizer
  • Diabetes UK
  • Department of Health, United Kingdom

Investigators

  • Study Director: Pfizer CT.gov Call Center, Pfizer

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00327418
Other Study ID Numbers:
  • 0981-430-102
  • A2581143
First Posted:
May 18, 2006
Last Update Posted:
May 10, 2007
Last Verified:
May 1, 2007
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 10, 2007